Home » Thought Leadership » Blogs » Page 8

Blogs

1

Showing 5 of 48 posts
PDx infographic for What are the Most Impactful Clinical Considerations for Commercial PDx Success?
April 25, 2019 | Blogs, Infographics

What are the Most Impactful Clinical Considerations for Commercial PDx Success?

CBPartners uncovers the most impactful clinical considerations for commercial PDx success in this handy infographic.

March 6, 2019 | Blogs

Applying Technology in Pharma (ATP): Assessment of Investment Trends in Digital Health

VC investment in digital healthcare has been growing rapidly (+42% vs. 2017) as the potential of new technology to solve complex issues, ranging from providing healthcare services to managing chronic conditions, evolves. CBPartners takes a look at investment trends in digital health.

February 21, 2019 | Blogs

Vermont’s Drug Importation: Rubber, Meet Road

Vermont’s fledgling drug importation law has undergone preliminary savings analysis, with uninspiring projections of a 3.8% drug cost savings rate. CBPartners evaluates the real impact of this new policy.

September 9, 2018 | Blogs

Evolving Reimbursement Dynamics in China

When the engine of innovation gets the green light of marketing authorisation, it is typically first in the USA, and sometimes for the EMA’s (European Medicines Agency) jurisdiction over much of Europe. Unfortunately, China is too often one the last markets among the major and highest-tier of emerging markets to be considered for broad patient access. CBPartners explores the evolving reimbursement dynamics in China.